Vistagen Therapeutics Inc (VTGN)
4.72
-0.11
(-2.28%)
USD |
NASDAQ |
Apr 24, 16:00
4.75
+0.03
(+0.64%)
After-Hours: 20:00
Vistagen Therapeutics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.1145 |
| March 31, 2023 | 0.0087 |
| December 31, 2022 | 0.0203 |
| September 30, 2022 | 0.0247 |
| June 30, 2022 | 0.0225 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.001 |
| September 30, 2020 | 0.1042 |
| June 30, 2020 | -0.0987 |
| March 31, 2020 | -0.0099 |
| December 31, 2019 | -0.0116 |
| September 30, 2019 | -0.0439 |
| June 30, 2019 | 0.1516 |
| March 31, 2019 | 0.0081 |
| December 31, 2018 | 0.029 |
| September 30, 2018 | 0.029 |
| June 30, 2018 | 0.0562 |
| March 31, 2018 | 0.0078 |
| December 31, 2017 | 0.0043 |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0629 |
| June 30, 2017 | -0.2727 |
| March 31, 2017 | 0.089 |
| December 31, 2016 | 0.0138 |
| September 30, 2016 | 0.0174 |
| June 30, 2016 | 0.0172 |
| March 31, 2016 | -0.0238 |
| December 31, 2015 | -0.0645 |
| September 30, 2015 | -0.104 |
| June 30, 2015 | -0.483 |
| March 31, 2015 | -0.6942 |
| December 31, 2014 | -0.6691 |
| September 30, 2014 | -0.6423 |
| June 30, 2014 | -0.5616 |
| March 31, 2014 | -0.5401 |
| December 31, 2013 | -0.5465 |
| September 30, 2013 | -0.4653 |
| June 30, 2013 | -0.4728 |
| March 31, 2013 | -0.4248 |
| December 31, 2012 | -0.4971 |
| September 30, 2012 | -0.4959 |
| June 30, 2012 | -0.534 |
| March 31, 2012 | -0.622 |
| December 31, 2011 | -0.6889 |
| September 30, 2011 | -0.7357 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0987
Minimum
Jun 2020
0.1516
Maximum
Jun 2019
0.0149
Average
--
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Ardelyx Inc | 0.2987 |
| Axsome Therapeutics Inc | 0.9324 |
| Vir Biotechnology Inc | 0.00 |
| Immuneering Corp | -- |
| NovaBay Pharmaceuticals Inc | 0.3431 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 131.07M |
| Total Liabilities (Quarterly) | 7.783M |
| Shareholders Equity (Quarterly) | 123.28M |
| Current Ratio | 30.76 |
| Net Debt Paydown Yield | 0.11% |